NuvOx Therapeutics, Inc. (NUOX) SEC Filings & Financial Intelligence
NuvOx Therapeutics, Inc. (NUOX) is a publicly traded company, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NUOX
CIK: 1966126
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Rosenberg Rich Baker Berman, P.A.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerSalvatore LubranoLavadera
Audit LocationSomerset, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-1/A | 2026-10-13 | — | REGISTRATION STATEMENT | 0001213900-26-108590 | View SEC Doc Filr Page |
| S-1/A | 2026-09-16 | — | REGISTRATION STATEMENT | 0001213900-26-100586 | View SEC Doc Filr Page |
| S-1 | 2026-07-17 | — | REGISTRATION STATEMENT | 0001213900-26-079095 | View SEC Doc Filr Page |
| DRS/A | 2025-05-06 | — | DRS/A Filing | 0001213900-25-040249 | View SEC Doc Filr Page |
| DRS/A | 2025-04-08 | — | DRS/A Filing | 0001213900-25-029981 | View SEC Doc Filr Page |
| DRS | 2024-12-23 | — | DRS Filing | 0001213900-24-111966 | View SEC Doc Filr Page |
| D | 2024-11-22 | — | D Filing | 0001213900-24-101639 | View SEC Doc Filr Page |
| D | 2023-02-15 | — | D Filing | 0001966126-23-000001 | View SEC Doc Filr Page |